newsfilter
← Latest News
Business Wire·

Biocept Reports 2021 Fourth Quarter and Full Year Financial Results

Fourth quarter net revenues of $14.0 million driven by RT-PCR COVID-19 testing volume Full year net revenues of $61.2 million increased 123% over the prior year Positive operating cash flow for 2021 of $3.7 million Cash and cash equivalent